Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Victory Swings Back To Gilenya Generics With Latest US Supreme Court Order
Topsy-Turvy Case Saw ‘Imminent’ Gilenya ANDA Launches Halted By Supreme Court
Oct 14 2022
•
By
Dean Rudge
Eight Gilenya ANDA products are approved • Source: Shutterstock
More from Legal & IP
More from Generics Bulletin